The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-((1H-benzo[d]imidazol-2-yl)methyl)-1,4-diazepan-1-yl)-N-(2-chlorophenyl)acetamide ID: ALA1096152
PubChem CID: 46888270
Max Phase: Preclinical
Molecular Formula: C21H24ClN5O
Molecular Weight: 397.91
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CN1CCCN(Cc2nc3ccccc3[nH]2)CC1)Nc1ccccc1Cl
Standard InChI: InChI=1S/C21H24ClN5O/c22-16-6-1-2-7-17(16)25-21(28)15-27-11-5-10-26(12-13-27)14-20-23-18-8-3-4-9-19(18)24-20/h1-4,6-9H,5,10-15H2,(H,23,24)(H,25,28)
Standard InChI Key: WVAGMVPNWFFVOO-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
6.3980 -8.1685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3996 -8.9940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1147 -9.4055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1060 -7.7528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8222 -8.1589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8294 -8.9903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0926 -8.5618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6126 -7.8992 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9324 -8.5683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3943 -9.2531 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.2214 -9.1281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8037 -9.7104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9813 -9.9684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7535 -10.5259 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2810 -10.7404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0686 -10.9856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4689 -10.9389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1836 -10.5262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1836 -9.7020 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6125 -10.5262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3281 -10.9393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0353 -10.5309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0353 -9.7101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3216 -9.2980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6098 -9.7089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3281 -11.7733 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.6170 -9.2360 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.8980 -10.9387 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
7 8 2 0
8 5 1 0
7 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
10 13 1 0
12 14 1 0
13 15 1 0
14 16 1 0
15 16 1 0
14 17 1 0
17 18 1 0
18 19 2 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
21 26 1 0
1 2 2 0
6 27 1 0
27 7 1 0
18 28 1 0
28 20 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 397.91Molecular Weight (Monoisotopic): 397.1669AlogP: 3.36#Rotatable Bonds: 5Polar Surface Area: 64.26Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.41CX Basic pKa: 6.46CX LogP: 2.70CX LogD: 2.65Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.69Np Likeness Score: -2.27
References 1. Gu SJ, Lee JK, Pae AN, Chung HJ, Rhim H, Han SY, Min SJ, Cho YS.. (2010) Synthesis and biological evaluation of 1,4-diazepane derivatives as T-type calcium channel blockers., 20 (9): [PMID:20382529 ] [10.1016/j.bmcl.2010.03.084 ]